Keywords
Coronavirus
Cardiovascular system
How to Cite
Abstract
COVID-19 infection is known for its respiratory implications, however multisystem complications, such as cardiovascular problems, must be considered. So far, there is a lack of understanding of the implications of COVID-19 infection on the cardiovascular system, and the objective of the present study is to carry out a systematic literature review to analyze this topic. The study followed the PRISMA guidelines, being searched in the Cochrane Library and PubMed databases for articles published up to 2022 and using descriptors such as “COVID”, “Coronavirus”, “Cardiovascular disease”, “long COVID”. Of the total of 4,538 articles initially found, after applying the inclusion and exclusion criteria, 9 studies were included in the review. Evidence indicates cardiovascular implications in patients post-COVID-19 infection, requiring adequate and effective strategies to recognize the acute and chronic nature of these implications and to deal with chronicity and morbidity.
References
Coccolini F., Cicuttin E., Cremonini C., et al. A pandemic recap: lessons we have learned. World J Emerg Surg. 2021;16(1):46.
Stenseth N.C., Dharmarajan G., Li R., et al. Lessons learnt from the COVID-19 pandemic. Front Public Health. 2021;9.
Stenseth N.C., Dharmarajan G., Li R., et al. Lessons learnt from the COVID-19 pandemic. Front Public Health. 2021;9
Elliott J., Whitaker M., Bodinier B., et al. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLoS Med. 2021;18(9).
Kompaniyets L., Pennington A.F., Goodman A.B., et al. Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020-March 2021. Prev Chronic Dis. 2021;18:E66.
Li B., Yang J., Zhao F., et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531–538.
Sanyaolu A., Marinkovic A., Prakash S., et al. Post-acute sequelae in COVID-19 survivors: an overview. SN Compr Clin Med. 2022;4(1):91.
Welty F.K., Rajai N., Amangurbanova M. Comprehensive review of cardiovascular complications of coronavirus disease 2019 and beneficial treatments. Cardiol Rev. 2022;30(3):145–157.
Schmid A., Petrovic M., Akella K., Pareddy A., Velavan S.S. Getting to the heart of the matter: myocardial injury, coagulopathy, and other potential cardiovascular implications of COVID-19. Int J Vasc Med. 2021;2021:6693895.
Moher D et al.. Preferred reporting items for systematic reviews and Meta-Analyses: the PRISMA statement (reprinted from annals of internal medicine). Phys Ther. 2009;89(9):873–880.
Barco S., Voci D., Held U., et al. Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial. Lancet Haematol. 2022;9(8):e585–e593.
Connors J.M., Brooks M.M., Sciurba F.C., et al. Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial. Jama. 2021;326(17):1703–1712.
Foged F., Rasmussen I.E., Bjørn Budde J., et al. Fidelity, tolerability and safety of acute high-intensity interval training after hospitalisation for COVID-19: a randomised cross-over trial. BMJ Open Sport Exerc Med. 2021;7(3)
Gonzalez-Ochoa A.J., Raffetto J.D., Hernández A.G., et al. Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial. Thromb Haemost. 2021;121(7):944–954.
Leucker T.M., Osburn W.O., Reventun P., et al. Effect of crizanlizumab, a P-selectin inhibitor, in COVID-19: a placebo-controlled, randomized trial. JACC Basic Transl Sci. 2021;6(12):935–945.
Lopes R.D., Macedo A.V.S., de Barros E.S.P.G.M., et al. Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial. JAMA. 2021;325(3):254–264.
Poncin W., Schalkwijk A., Vander Straeten C., et al. Impact of surgical mask on performance and cardiorespiratory responses to submaximal exercise in COVID-19 patients near hospital discharge: a randomized crossover trial. Clin Rehabil. 2022;36(8):1032–1041.
Sholzberg M., Tang G.H., Rahhal H., et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. Bmj. 2021;375.
Teixeira D.O.A.V., Viana A.A., Heubel A.D., et al. Cardiovascular, respiratory, and functional effects of home-based exercise training after COVID-19 hospitalization. Med Sci Sports Exerc. 2022;54(11):1795–1803.
Cenko E., Badimon L., Bugiardini R., et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on Coronary Pathophysiology & Microcirculation, ESC working group on thrombosis and the Association for Acute CardioVascular care (ACVC), in collaboration with the European heart rhythm association (EHRA) Cardiovasc Res. 2021;117(14):2705–2729.
Goyal P., Choi J.J., Pinheiro L.C., et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372–2374.
Krishna H., Ryu A.J., Scott C.G., et al. Cardiac abnormalities in COVID-19 and relationship to outcome. Mayo Clin Proc. 2021;96(4):932–942.
Arévalos V., Ortega-Paz L., Rodríguez-Arias J.J., et al. Acute and chronic effects of COVID-19 on the cardiovascular system. J Cardiovasc Dev Dis. 2021;8(10).
Umbrajkar S., Stankowski R.V., Rezkalla S., Kloner R.A. Cardiovascular health and disease in the context of COVID-19. Cardiol Res. 2021;12(2):67–79.
Guzik T.J., Mohiddin S.A., Dimarco A., et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666–1687.
Wulf Hanson S., Abbafati C., Aerts J.G., et al. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv. 2022.
Cutler D.M. The costs of Long COVID. JAMA Health Forum. 2022;3(5):e221809.
Faghy M.A., Owen R., Thomas C., et al. Is long COVID the next global health crisis? Journal of. Glob Health. 2022:12.
Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232.
Tronco Hernández Y.A., Parente F., Faghy M.A., Roscoe C.M.P., Maratos F.A. Influence of the COVID-19 lockdown on the physical and psychosocial well-being and work productivity of remote workers: cross-sectional correlational study. JMIRx Med. 2021;2(4).
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Giovanna Gabriela Santos Felix Cavalcanti , Ana Claudia Rodrigues da Silva , Ayara Almeida Souza Cabral , Bruna Rafaela da Silva Santos , Natalha Cabral do Nascimento , Camila Yohanna Lira Sousa , Alycia Antunes de Carvalho , Alynne Saphira Araújo Costa , Ailla Gabrielli Costa Silva , Rafael Pereira dos Santos , Teresa Victória Costa da Silva , Felipe Cardoso Rodrigues Vieira